[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11

Título :	Dopamine d3 receptor ser9gly polymorphism and risperidone response
Tipo de documento:	texto impreso
Autores:	Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 6-11
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social
Resumen:	Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms.
Link:	./index.php?lvl=notice_display&id=30920

[artículo] Dopamine d3 receptor ser9gly polymorphism and risperidone response [texto impreso] / Hsien Yuan Lane, Autor ; Shih-Kuan Hsu, Autor ; Yi-Ching Liu, Autor . - 2023 . - pp. 6-11.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 1 (Febrero) . - pp. 6-11

Palabras clave:	Antipsicóticos, ADN - genética, Polimorfismo, Genética, Receptores de Dopamina D2, Risperidona, Esquizofrenia, Comportamiento social
Resumen:	Risperidone is an atypical antipsychotic agent with efficacy for both positive and negative symptoms of schizophrenia. Risperidone is a potent dopamine D3 antagonist and agonism at D3 sites induces behavioral suppression in rodents. We thus hypothesized that D3 antagonism may contribute to response to risperidone in negative symptoms.
Link:	./index.php?lvl=notice_display&id=30920